UAB launches three initiatives to stimulate personalized medicine care, research
Written by Clinton Colmenares
The University of Alabama Board of Trustees approved the creation of the Personalized Medicine Institute, the Institute for Informatics and the UAB-HudsonAlpha Center for Genomic Medicine.
UAB School of Medicine, HudsonAlpha create joint Center for Genomic Medicine
Written by Clinton Colmenares
The UAB-HudsonAlpha Center for Genomic Medicine will span human genome research with clinical care.
Neurologist David Geldmacher, M.D., is launching a new clinical effort to prepare a personalized dementia risk assessment for people concerned about their risk for developing memory problems as they age.
Anthony Nicholas, M.D., associate professor in the Department of Neurology, is a co-editor of the first textbook on the subject of protein deimination in human health and disease.
Selections are based on quantitative analysis of peer-reviewed articles in medical journals.
LRRK2 inhibitors may be key to combating Parkinson’s disease, UAB study says
Written by Matt Windsor
New drugs to slow or even prevent Parkinson’s could be in human studies as early as 2015.
Professor of Surgery Mary T. Hawn, M.D., and Professor of Pathology Robin G. Lorenz, M.D., Ph.D.,were named fellows to the Hedwig van Ameringen Executive Leadership in Academic Medicine® Program.
Researchers participated in a multi-site study that disproved a once-promising theory that statins might have a beneficial effect on lung function.
Researchers at the University of Alabama at Birmingham have identified a strategy that highly aggressive brain tumor cells use to fuel their relentless expansion.
New test measuring cell bioenergetic health could become key tool in personalized medicine
Written by Clinton Colmenares
UAB researchers have created a blood test that determines a bioenergetic index which could become an important method of measuring mitochondrial health in patients with chronic disease.